Growth modeling of the maternal cytokine milieu throughout normal pregnancy: Macrophage-derived chemokine decreases as inflammation/counterregulation increases

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Holtan, Shernan G ^a   Chen, Yiyi ^b   Kaimal, Rajani ^b   Creedon, Douglas J ^c   Enninga, Elizabeth Ann L ^d   Nevala, Wendy K ^d   Markovic, Svetomir N ^c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CD40 LIGAND; FIBROBLAST GROWTH FACTOR 2; FLT3 LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PLATELET DERIVED GROWTH FACTOR AA; RANTES; VASCULOTROPIN; CYTOKINE; SIGNAL PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFLAMMATION; LIMIT OF DETECTION; LONGITUDINAL STUDY; MATERNAL BLOOD; PREGNANT WOMAN; TIME; BLOOD; GENE EXPRESSION PROFILING; IMMUNOLOGY; MACROPHAGE; METABOLISM; PREGNANCY;

CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; PREGNANCY;

EID: 84926482968     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/952571     Document Type: Article

References (36)

1. A. E. Curry, I. Vogel, K. Skogstrand et al., "Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors," Journal of Reproductive Immunology, Vol. 77, no. 2, pp. 152-160, 2008.
2. T. A. Kraus, R. S. Sperling, S. M. Engel et al., "Peripheral blood cytokine profiling during pregnancy and post-partum periods," The American Journal of Reproductive Immunology, Vol. 64, no. 6, pp. 411-426, 2010.
3. J. M. Denney, E. L. Nelson, P. D. Wadhwa et al., "Longitudinal modulation of immune system cytokine profile during pregnancy," Cytokine, Vol. 53, no. 2, pp. 170-177, 2011.
4. D. J. Jamieson, M. A. Honein, S. A. Rasmussen et al., "H1N1 2009 influenza virus infection during pregnancy in the USA," The Lancet, Vol. 374, no. 9688, pp. 451-458, 2009.
5. D. Getahun, M. J. Fassett, G. F. Longstreth et al., "Association between maternal inflammatory bowel disease and adverse perinatal outcomes," Journal of Perinatology, Vol. 34, no. 6, pp. 435-440, 2014.
6. A. E. Curry, I. Vogel, C. Drews et al., "Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery," Acta Obstetricia et Gynecologica Scandinavica, Vol. 86, no. 9, pp. 1103-1110, 2007.
7. J. W. Gargano, C. Holzman, P. Senagore et al., "Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth," Journal of Reproductive Immunology, Vol. 79, no. 1, pp. 100-110, 2008.
8. P. Tsiartas, R. M. Holst, U. B. Wennerholm et al., "Prediction of spontaneous preterm delivery in women with threatened preterm labour: a prospective cohort study of multiple proteins in maternal serum," British Journal of Obstetrics and Gynaecology, Vol. 119, no. 7, pp. 866-873, 2012.
9. J. A. Brewster, N. M. Orsi, N. Gopichandran, P. McShane, U. V. Ekbote, and J. J. Walker, "Gestational effects on host inflammatory response in normal and pre-eclamptic pregnancies," European Journal of Obstetrics Gynecology and Reproductive Biology, Vol. 140, no. 1, pp. 21-26, 2008.
10. A. Molvarec, A. Szarka, S. Walentin et al., "Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia," Reproductive Biology and Endocrinology, Vol. 9, article 124, 2011.
11. E. R. Unal, J. T. Cierny, C. Roedner, R. Newman, and L. Goetzl, "Maternal inflammation in spontaneous term labor," American Journal of Obstetrics & Gynecology, Vol. 204, no. 3, pp. 223.e1-223.e5, 2011.
12. W. de Jager, K. Bourcier, G. T. Rijkers, B. J. Prakken, and V. Seyfert-Margolis, "Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays," BMC Immunology, Vol. 10, article 52, 2009.
13. R. W. Hornung and L. D. Reed, "Estimation of average concentration in the presence of nondetectable values," Applied Occupational and Environmental Hygiene, Vol. 5, no. 1, pp. 46-51, 1990.
14. R. Patil, S. Shukre, R. Paranjape, and M. Thakar, "Heparin and EDTA anticoagulants differentially affect the plasma cytokine levels in humans," Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, no. 5, pp. 452-455, 2013.
15. J. H. Ward, "Hierarchical grouping to optimize an objective function," Journal of the American Statistical Association, Vol. 58, pp. 236-244, 1963.
16. H. Akaike, "Information theory and an extension of the maximum likelihood principle," in Proceedings of the 2nd International Symposium on Information Theory, pp. 267-281, 1973.
17. G. P. Sacks, K. Studena, I. L. Sargent, and C. W. G. Redman, "Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis," The American Journal of Obstetrics and Gynecology, Vol. 179, no. 1, pp. 80-86, 1998.
18. S. J. Germain, G. P. Sacks, S. R. Sooranna, I. L. Sargent, and C. W. Redman, "Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotro-phoblast microparticles," The Journal of Immunology, Vol. 178, no. 9, pp. 5949-5956, 2007.
19. X. Jiang, H. Y. Bar, J. Yan et al., "Pregnancy induces transcriptional activation of the peripheral innate immune system and increases oxidative DNA damage among healthy third trimester pregnant women," PLoS ONE, Vol. 7, no. 11, Article ID e46736, 2012.
20. R. Agarwal, A. Loganath, A. C. Roy, Y. C. Wong, and S. C. Ng, "Expression profiles of interleukin-15 in early and late gestational human placenta and in pre-eclamptic placenta," Molecular Human Reproduction, Vol. 7, no. 1, pp. 97-101, 2001.
21. C. L. Elliott, J. A. Z. Loudon, N. Brown, D. M. Slater, P. R. Bennett, and M. H. F. Sullivan, "IL-1β and IL-8 in human fetal membranes: changes with gestational age, labor, and culture conditions," American Journal of Reproductive Immunology, Vol. 46, no. 4, pp. 260-267, 2001.
22. K. H. Grabstein, J. Eisenman, K. Shanebeck et al., "Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor," Science, Vol. 264, no. 5161, pp. 965-968, 1994.
23. K. A. Hogquist, E. R. Unanue, and D. D. Chaplin, "Release of IL-1 from mononuclear phagocytes," Journal of Immunology, Vol. 147, no. 7, pp. 2181-2186, 1991.
24. M. Phillippe, "Cell-free fetal DNA - a trigger for parturition," The New England Journal of Medicine, Vol. 370, no. 26, pp. 2534-2536, 2014.
25. R. Godiska, D. Chantry, C. J. Raport et al., "Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells," Journal of Experimental Medicine, Vol. 185, no. 9, pp. 1595-1604, 1997.
26. D. P. Andrew, M.-S. Chang, J. McNinch et al., "STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13," Journal of Immunology, Vol. 161, no. 9, pp. 5027-5038, 1998.
27. C. Wilhelm, K. Hirota, B. Stieglitz et al., "An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation," Nature Immunology, Vol. 12, no. 11, pp. 1071-1077, 2011.
28. J.-B. Demoulin and J.-C. Renauld, "Interleukin 9 and its receptor: an overview of structure and function," International Reviews of Immunology, Vol. 16, no. 3-4, pp. 345-364, 1998.
29. K. K. Ferguson, T. F. McElrath, Y.-H. Chen, B. Mukherjee, and J. D. Meeker, "Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy," American Journal of Reproductive Immunology, Vol. 72, no. 3, pp. 326-336, 2014.
30. A. Biancotto, X. Feng, M. Langweiler, N. S. Young, and J. Philip McCoy, "Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects," Cytokine, Vol. 60, no. 2, pp. 438-446, 2012.
31. J. Hanna, D. Goldman-Wohl, Y. Hamani et al., "Decidual NK cells regulate key developmental processes at the human fetalmaternal interface," Nature Medicine, Vol. 12, no. 9, pp. 1065-1074, 2006.
32. A. Szarka, J. Rigó Jr., L. Lázár, G. Beko, and A. Molvarec, "Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array," BMC Immunology, Vol. 11, article 59, 2010.
33. A. I. Loewendorf, T. A. Nguyen, M. N. Yesayan, and D. A. Kahn, "Normal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface," PLoS ONE, Vol. 9, no. 5, Article ID e96723, 2014.
34. T. G. Wegmann, H. Lin, L. Guilbert, and T. R. Mosmann, "Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?" Immunology Today, Vol. 14, no. 7, pp. 353-356, 1993.
35. H. Lin, T. R. Mosmann, L. Guilbert, S. Tuntipopipat, and T. G. Wegmann, "Synthesis of T helper 2-type cytokines at the maternal-fetal interface," The Journal of Immunology, Vol. 151, no. 9, pp. 4562-4573, 1993.
36. A. Doria, M. Cutolo, A. Ghirardello et al., "Effect of pregnancy on serum cytokines in SLE patients," Arthritis Research and Therapy, Vol. 14, no. 2, article R66, 2012.